A Clinical Trial to Assess Pharmacokinetic/Pharmacodynamic Profiles and Safety of IVL3001

Finasteride Treatment of Severe Nodulocystic Acne

NCT02502669 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Platelet Rich Plasma in Androgenetic Alopecia

NCT02074943 ·Status: UNKNOWN ·Phase: NA

Evaluation of Efficacy and Safety of Oral Minoxidil 1 mg in Female Androgenetic Alopecia

NCT05888922 ·Status: RECRUITING ·Phase: PHASE3

Safety, Tolerability and Pharmacokinetics of KX826 in Healthy Male Subjects With Androgenetic Alopecia Following Topical Single Ascending Dose Administration

NCT04984707 ·Status: COMPLETED ·Phase: PHASE1

Phase I Clinical Trial of CG2001 in Chinese Adult Male Participants With Androgenetic Alopecia

NCT07038941 ·Status: COMPLETED ·Phase: PHASE1

Clinical Trial of Safety and Efficacy of Daily Application of Topical Dutasteride in Men With Androgenic Alopecia.

NCT05599243 ·Status: COMPLETED ·Phase: PHASE2

Clinical Trial to Evaluate CG2001 in Chinese Adult Male Participants With Androgenetic Alopecia

NCT07076706 ·Status: COMPLETED ·Phase: PHASE2

Clinical Trial in Females With Female Pattern Hair Loss

NCT01145625 ·Status: COMPLETED ·Phase: PHASE3

A Randomized, Double-blind Clinical Trial to Evaluate the Safety and Efficacy of the X5 HairLaser for the Treatment of Androgenetic Alopecia in Males

NCT02067260 ·Status: COMPLETED ·Phase: NA

A Clinical Traial to Assess Pharmacokinetic/Pharmacodynamic Profiles and Safety of CKD-843

NCT04805606 ·Status: COMPLETED ·Phase: PHASE1

A First in Human Single and Multiple Ascending Dose and Open Label Food Effect Study of OR-101 in Healthy Subjects

NCT06045624 ·Status: WITHDRAWN ·Phase: PHASE1

Investigate the Efficacy and Safety of Farudodstat Compared With Its Placebo in Adult Alopecia Areata Participants

NCT05865041 ·Status: RECRUITING ·Phase: PHASE2

Evaluation of the Safety, Tolerability and Pharmacokinetics of AH-001 Following Topical Single and Multiple Ascending Dose Administration

NCT06927960 ·Status: COMPLETED ·Phase: PHASE1

Topical or Oral Minoxidil for the Treatment of Endocrine Therapy-Induced Alopecia in Patients With Stage I-IV Breast Cancer

NCT05417308 ·Status: RECRUITING ·Phase: EARLY_PHASE1

Efficacy/ Safety of DNN.22.17.036 in Male Patients With Pattern Hair Loss

NCT06355856 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4

Phase 2 Trial of BNZ-1 in Patients With Moderate to Severe Alopecia Areata

NCT03532958 ·Status: WITHDRAWN ·Phase: PHASE2

PF-06651600 for the Treatment of Alopecia Areata

NCT03732807 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

The Parallel Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of CKD-843 A

NCT05587699 ·Status: COMPLETED ·Phase: PHASE1

A Phase II Study in Patients With Alopecia Areata

NCT04346316 ·Status: COMPLETED ·Phase: PHASE2

Efficacy & Safety of Minoxidil SL Tablets in Men With AGA

NCT06924632 ·Status: COMPLETED ·Phase: PHASE3

Dutasteride Versus Placebo and Finasteride in Men With Androgenetic Alopecia

NCT01231607 ·Status: COMPLETED ·Phase: PHASE3

Study To Evaluate The Efficacy And Safety Profile Of PF-06651600 And PF-06700841 In Subjects With Alopecia Areata

NCT02974868 ·Status: COMPLETED ·Phase: PHASE2

Effect of Low-Dose Oral Minoxidil as Treatment of Permanent Chemotherapy-Induced Alopecia

NCT03831334 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1

Study to Evaluate the Efficacy and Safety of P-3074 Topical Solution in the Treatment of Androgenetic Alopecia

NCT03004469 ·Status: COMPLETED ·Phase: PHASE3

A Clinical Trial to Examine the Efficacy of a Dietary Supplement to Improve the Health and Appearance of Hair.

NCT06515496 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA